GRANT PICKERING - 11 Mar 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
11 Mar 2024
Net transactions value
+$131,950
Form type
4
Filing time
13 Mar 2024, 16:22:13 UTC
Previous filing
04 Mar 2024
Next filing
27 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $131,950 +65,000 +16% $2.03 477,847 11 Mar 2024 Direct
holding PCVX Common Stock 148,670 11 Mar 2024 By Children's Trust F1
holding PCVX Common Stock 148,670 11 Mar 2024 By Children's Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -65,000 -22% $0.000000 227,327 11 Mar 2024 Common Stock 65,000 $2.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
F2 Shares are held directly by a trust for the benefit of the Reporting Person's son.
F3 Stock Option is fully vested and exercisable.